[1] Sorting out the new HSV type specific antibody tests

[2] Twelve years of European cancer drug approval-a systematic investigation of the 'magnitude of clinical benefit'

[3] drug lag for cardiovascular drug approvals in india compared with the us and eu approvals

[4] Twelve years of European cancer drug approval-a systematic investigation of the 'magnitude of clinical benefit'